Article Details

AstraZeneca invests in Imperial's self-amplifying RNA technology with eye on future drugs | Reuters

Retrieved on: 2021-09-23 06:00:00

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca invests in Imperial's self-amplifying RNA technology with eye on future drugs | Reuters. View article details on hiswai:

Excerpt

AstraZeneca already produces an adenoviral vector COVID-19 vaccine, and emphasised the potential of the self-amplifying RNA (saRNA) technology in novel ...

Article found on: www.reuters.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up